Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Joshua

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Methods in Molecular Medicine|June 22, 2005
Multiple myeloma: challenges and opportunitiesDouglas Joshua, Ross Brown, P Joy Ho
Current Drug Targets|December 15, 2010
Interferon-alpha in the treatment of multiple myelomaTeh Liane Khoo, Annette Juul Vangsted, Douglas Joshua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2008
Individualizing treatment of patients with myeloma in the era of novel agentsJesús San-Miguel, Jean-Luc Harousseau, Douglas Joshua, et al.
British Journal of Haematology|March 29, 2002
Phenotyping primitive plasma cellsDouglas Joshua, Belinda Pope, Ross Brown, et al.
Reviews in Clinical and Experimental Hematology|March 6, 2003
The biology and cytogenetics of multiple myelomaP Joy Ho, Lynda J Campbell, John Gibson, et al.
Current Cancer Drug Targets|July 20, 2006
The use of thalidomide in myeloma therapy as an effective anticancer drugDaniel M-Y Sze, Ross Brown, Shihong Yang, et al.
Oncoimmunology|December 25, 2012
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myelomaRoss Brown, Hayley Suen, James Favaloro, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
The T Cell in MyelomaDouglas Joshua, Hayley Suen, Ross Brown, et al.
Blood Cancer Journal|March 15, 2020
A liquid biopsy to detect multidrug resistance and disease burden in multiple myelomaSabna Rajeev Krishnan, Gabriele De Rubis, Hayley Suen, et al.
International Journal of Environmental Research and Public Health|March 23, 2018
Quality of Patient-Centered Care Provided to Patients Attending Hematological Cancer Treatment CentersFlora Tzelepis, Tara Clinton-McHarg, Christine L Paul, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Methods in Molecular Medicine|June 22, 2005
Multiple myeloma: challenges and opportunitiesDouglas Joshua, Ross Brown, P Joy Ho
Current Drug Targets|December 15, 2010
Interferon-alpha in the treatment of multiple myelomaTeh Liane Khoo, Annette Juul Vangsted, Douglas Joshua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2008
Individualizing treatment of patients with myeloma in the era of novel agentsJesús San-Miguel, Jean-Luc Harousseau, Douglas Joshua, et al.
British Journal of Haematology|March 29, 2002
Phenotyping primitive plasma cellsDouglas Joshua, Belinda Pope, Ross Brown, et al.
Reviews in Clinical and Experimental Hematology|March 6, 2003
The biology and cytogenetics of multiple myelomaP Joy Ho, Lynda J Campbell, John Gibson, et al.
Current Cancer Drug Targets|July 20, 2006
The use of thalidomide in myeloma therapy as an effective anticancer drugDaniel M-Y Sze, Ross Brown, Shihong Yang, et al.
Oncoimmunology|December 25, 2012
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myelomaRoss Brown, Hayley Suen, James Favaloro, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
The T Cell in MyelomaDouglas Joshua, Hayley Suen, Ross Brown, et al.
Blood Cancer Journal|March 15, 2020
A liquid biopsy to detect multidrug resistance and disease burden in multiple myelomaSabna Rajeev Krishnan, Gabriele De Rubis, Hayley Suen, et al.
International Journal of Environmental Research and Public Health|March 23, 2018
Quality of Patient-Centered Care Provided to Patients Attending Hematological Cancer Treatment CentersFlora Tzelepis, Tara Clinton-McHarg, Christine L Paul, et al.
Pageof 5